Bio Path Holdings Inc (BPTH)

[wordlender]

It’s not a scam. You can call the research centers where the clinical trials are happening and ask them about biopath and prexigerbersen.

We do have a huge problem however; we need at least $5mil to complete phase 2. We really need at least $10mil to get to commercialization.

An investor buying $10 mil of our stock will require a price around 0.50-0.60 per share. That would give this investor a controlling interest in the company. I’m not sure how BPTH will raise money, because they won’t make a deal like that.

$5mil @ 0.80 is 6 mil shares. Not quite a controlling interest but close. That also assumes they can get that price. A deal is more likely at a lower price.

Any amount of shares will cause dilution preventing a deal at the current price. To get the money we need, BPTH needs to practically sell the entire company.

Unless a licensing deal happens or they sell prexigerbersen itself, I think we might literally run out of money.